Random numbers were generated in Excel to divide the 60 rats into a normal control group (NG) and a PCOS model group (PMG), each consisting of 10 rats, as well as a berberine group (BG), a JPYSHZF group (JG), a combination group of berberine with the JPYSHZF (BJG), and a metformin group (MG), with 10 animals in each metformin group
Endotoxin testing and contamination control are separate processes that occur through analytical testing, quality-control procedures, and validated laboratory practices
the analog is: hexanoic-tyrosine-isoleucme-(6)-amino-hexanoic amide
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
